It is reported by RIA Novosti with reference to the press service of the Ministry of Health.
It is noted that so far this drug is not registered in Russia
“The positive results of the limited clinical research program will allow the initiation of the state registration procedure with the establishment of post-registration measures regarding, inter alia, the appointment of studies in the post-registration period,” the text says.
The Ministry of Health summarized that this would significantly reduce the time needed to bring the drug to the market.
Earlier, Russian Minister of Health Mikhail Murashko said that the first result on vaccines for coronavirus could appear in late July.